CHICAGO – Malignancy rates in patients with psoriasis outstrip those in the general population, based on data from a retrospective analysis of commercial claims.
Rates for all cancers were similar...
A substantial proportion of older adults in the United States undergo unnecessary and even harmful screening for colon, prostate, breast, and cervical cancer, contrary to clear guidelines that are...
A Food and Drug Administration proposal to regulate e-cigarettes does not go far enough, the American Society of Clinical Oncology and the American Association for Cancer Research say.
The two...
Treatment with tumor necrosis factor inhibitors does not appear to increase the rate of breast cancer recurrence among patients with rheumatoid arthritis, according to findings from a Swedish...
One-time-only screening for colorectal cancer using flexible sigmoidoscopy reduced colorectal cancer incidence by 20% and colorectal cancer–specific mortality by 27% in a Norwegian study involving...
Prophylactic aspirin therapy of at least 5 years’ duration has a favorable benefit-harm profile, primarily because of its effectiveness in preventing colorectal and other cancers, according to a...
The use of inpatient medical consultations for hospitalized surgical patients was found to vary by hospital, but consultations didn’t appear to have much of an impact on risk-adjusted 30-day...
Three to four years of therapy with the bisphosphonates alendronate and zoledronic acid, taken at doses used to treat osteoporosis, did not decrease the risk of incident breast cancer in...
The addition of a gut microbiome analysis to fecal occult blood testing improved the accuracy of standard colorectal cancer screening by more than 50-fold.
The expanded analysis not only...
Physicians can reduce liability and mitigate the risk of poor-quality drugs by taking advantage of a new federal law that tightens oversight on drug compounding facilities.
The ongoing...
